Comparison of the efficacy of adalimumab and ustekinumab for prevention of intestinal fibrosis in bio-naive Crohn's Disease patients

被引：0
|
作者：
Biscanin, A. [1 ,2 ]
Tomasic, V. [1 ]
Babic, F. [1 ]
Cacic, P. [1 ]
Kordej, D. Ogresta [1 ]
Hrabar, D. [1 ,2 ]
Kralj, D. [1 ]
Dorosulic, Z. [1 ]
机构：
[1] Sisters Char Univ Hosp, Dept Gastroenterol, Zagreb, Croatia
[2] Univ Zagreb, Sch Med, Zagreb, Croatia
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P565
引用
收藏
页码：695 / 695
页数：1
相关论文
共 50 条
  • [31] Disease Severity Among Bio-Naive RA Patients on Csdmards
    Harrold, Leslie R.
    Griffith, Jenny
    Litman, Heather J.
    Feng, Hua
    Schlacher, Casey A.
    Kremer, Joel
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [32] Efficacy of Ustekinumab Therapy in Patients With Perianal Crohn's Disease
    Manski, Scott
    Dioguardi, Vincent
    Weil, Blake J.
    Edirisuriya, Chelsea
    Gandhi, Hema K.
    Shivashankar, Raina
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S847 - S847
  • [33] Leukocyte Adhesive Function as Potential Predictive Marker for Treatment Response to Vedolizumab Among Bio-naive Patients with Crohn's Disease
    Liu, J.
    Cheng, Q.
    Cao, Q.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1077 - I1078
  • [34] EFFICACY OF USTEKINUMAB IN THE TREATMENT OF FIBROSTENOTIC CROHN'S DISEASE AS ASSESSED BY INTESTINAL ULTRASOUND
    St-Pierre, Joelle
    Rosentreter, Ryan E.
    Kiraly, Andrew
    Szostakiwskyj, Jessie Hart
    Novak, Kerri L.
    Panaccione, Remo
    Kaplan, Gilaad
    Devlin, Shane M.
    Seow, Cynthia H.
    Ingram, Richard J.
    Ma, Christopher
    El Ouali, Sara
    Rieder, Florian
    Wilson, Stephanie R.
    Medellin, Alexandra
    Lu, Cathy
    GASTROENTEROLOGY, 2023, 164 (06) : S1124 - S1124
  • [35] Vedolizumab Outcomes in Real-world Bio-naive Ulcerative Colitis and Crohn's Disease Patients (EVOLVE) in North America
    Yarur, Andres
    Bassel, Marielle
    Stein, Dara
    Kim, Hankyul
    Radulescu, Gabriela
    Lopez, Claudia
    Lissoos, Trevor
    Demuth, Dirk
    Bressler, Brian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S374 - S374
  • [36] A propensity score-matched comparison of infliximab and adalimumab in naive and nonnaive patients with Crohn's disease
    Orlando, A.
    Macaluso, F. S.
    Fries, W.
    Privitera, A. C.
    Cappello, M.
    Siringo, S.
    Inserra, G.
    Magnano, A.
    Di Mitri, R.
    Belluardo, N.
    Scarpulla, G.
    Magri, G.
    Trovatello, N.
    Carroccio, A.
    Genova, S.
    Bertolami, C.
    Vassallo, R.
    Ventimiglia, M.
    Renna, S.
    Orlando, R.
    Rizzuto, G.
    Cottone, M.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S399 - S399
  • [37] Long-term effectiveness and safety of ustekinumab in bio-naive and bio-experienced anti-tumor necrosis factor patients with Crohn's disease: a real-world multicenter Brazilian study
    Parra, Rogerio Serafim
    Fonseca Chebli, Julio Maria
    Freitas Queiroz, Natalia Sousa
    Mourao Cintra Damiao, Aderson Omar
    Cardoso de Azevedo, Matheus Freitas
    Chebli, Liliana Andrade
    Bertges, Erika Ruback
    Tiburcio Alves Junior, Antonio Jose
    Ambrogini Junior, Orlando
    Pona Schiavetti da Silva, Bianca Loyo
    Lubini, Marcio
    Bafutto, Mauro
    Flores, Cristina
    Vilela, Eduardo Garcia
    Boratto, Sandra Felice
    Tricarico Gasparetti Junior, Newton Luiz
    Steinwurz, Flavio
    Carvalho, Nayara Salgado
    Feres, Omar
    Ribeiro da Rocha, Jose Joaquim
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [38] Safety and efficacy of adalimumab in pediatric Crohn's disease patients
    Green, Alex
    Wyneski, Matthew
    Wyllie, Robert
    Kay, Marsha
    Mahajan, Lori
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S490 - S490
  • [39] A Comparison of Ultrasound Responsiveness in Bio-Naive and Bio-Experienced Rheumatoid Arthritis Patients
    Sabido-Sauri, Ricardo
    Tsechelidis, Ozun
    Acikgoz, Seyyid
    Gazel, Ummugulsum
    Sangwa, Sylvia
    Ivory, Catherine
    Hepworth, Elliot
    Aydin, Sibel
    JOURNAL OF RHEUMATOLOGY, 2024, 51 : 74 - 75
  • [40] Vedolizumab outcomes in real-world bio-naive ulcerative colitis and Crohn's disease patients (EVOLVE) in Canada: Interim results
    Bressler, B.
    Greenup, A. -J.
    Bassel, M.
    Stein, D.
    Soni, M.
    Radulescu, G.
    Neish, C.
    Khalid, J. M.
    Demuth, D.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S382 - S382
12345